Skip to Content

Complement-based Drug Development Summit Europe

Start Date:
Tuesday, 20 March, 2018
End Date:
Thursday, 22 March, 2018 4:00pm
Speciality:
Internal Medicine
Website:
http://go.evvnt.com/169759-0

The Complement-based Drug Development Summit Europe is the first industry-dedicated meeting focused on optimizing clinical trial design, efficacy assessment, target identification and expansion beyond orphan diseases. Across 3 content-packed days, the field's thought leaders from GSK, Novartis, Complement Pharma and many more will be sharing their insight and lessons learned, collectively enabling the community to: - Analysing Points of Inhibition: Assess the most effective points of complement inhibition for the treatment of individual diseases and the selection of therapeutic approaches for inhibition.- Optimise Clinical Trial Design: Fine-tune clinical trial design for expansion beyond orphan diseases, advancing patient stratification, targeting, dosing, endpoints and sample handling.- Standardising Efficacy Assessment: Define the next steps toward achieving standardisation of robust, functional assays in order to accurately determine treatment efficacy.- Advancing Safety Profiles: Ensure patient safety by enhancing the management of off-target effects and approaches for minimising infection risk.- Navigating the Regulatory Landscape: Streamline the regulatory approval process by examining guidelines and expectations, ensuring that drugs reach the market smoothly.

Join the Complement-based Drug Development Summit Europe to build the scaffold upon which complement therapeutics can be expanded beyond the treatment of ultra-rare diseases. URL: Brochure: https://go.evvnt.com/169759-2 Prices: Gold: Conference and 2 Workshops: GBP 2997, Silver: Conference and 1 Workshops: GBP 2598, Bronze: Conference only: GBP 1999, Workshop: GBP 599 Speakers: Anna Schubart (Novartis), Andrea Tenner (University of California), Michael Holers (University of Colorado), Paul Morgan (Cardiff University), Eva-Maria Nichols (GlaxoSmithKline), Michael Kirschfink (University of Heidelberg), Frank Baas (Complement Pharma), Ashley Frazer-Abel (Exsera Biolabs), Andrea Tenner (University of California), Anna Blom (Lund University), Anne Bruns (aHUS Foundation), Erik Hack (Prothix), Kiran Nistala (GlaxoSmithKline), Kai Höhlig (Aptarion Biotech AG), Richard Smith Director (King's College London), Tom Mollnes (University of Oslo)

Location

Hilton London Olympia,
380 Kensington High Street,
Kensington,
London,
W14 8NL,
United Kingdom

Organizer Details

Conference organized by Hanson Wade Ltd

Phone:
+4402031418700
Email:
infohansonwade@gmail.com

Medical conference data provided by Meetings4Docs. Report a problem >

Upcoming Related Conferences

Mar 20

International Conference on Internal Medicine 23 - 24 April JW Marriott Hotel Dubai Abu Baker Al Siddique Rd, Hamarain Shopping Center, Deira, Dubai, UAE PO Box 16590
Listed in: Nephrology, Immunology, Hepatology, Cardiology, Endocrinology, Urology, Infectious Disease, Pediatrics

Mar 20

2nd Annual NASH Summit 2018 23 - 25 April Massachusetts
Listed in: Internal Medicine

Mar 20

International Medical Forum 25 - 27 April Ukraine, Kiev, EC KievExpoPlaza, Salutnaya Str., 2-B
Listed in: Oncology, Dermatology, Nephrology, Neurology, Gastroenterology, Immunology, Pain Management, Psychiatry

Mar 20

McMaster Critical Care Update 26 - 26 April Ontario, Canada
Listed in: Internal Medicine, Emergency Medicine, Critical Care

Mar 20

ICOH 2018 29 April - 4 May Ireland
Listed in: Internal Medicine

Hide